Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Market overview • Consumables • Instruments PART 07: Market segmentation by end-user • Market overview • Hospitals and clinics • Clinical diagnostic laboratories • Home care settings PART 08: Geographical segmentation • Market overview • POC blood glucose monitoring devices market in Americas • POC blood glucose monitoring devices market in EMEA • POC blood glucose monitoring devices market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Growing adoption of minimally invasive and technologically superior products • Increase in online marketing strategies • Product bundling PART 12: Vendor landscape • Competitive landscape PART 13: Key vendor analysis • Alere • F. Hoffmann-La Roche • LifeScan • Key companies to watch • Other prominent vendors PART 14: Appendix • List of abbreviations List of Exhibits  Exhibit 01: Flow of market for POC blood glucose monitoring devices in 2016 Exhibit 02: Global POC blood glucose monitoring devices in 2016: Market highlights Exhibit 03: Global POC blood glucose monitoring devices 2016-2021 ($ millions) Exhibit 04: Global POC blood glucose monitoring devices market 2016: Market metric analysis Exhibit 05: Five forces analysis Exhibit 06: Global POC blood glucose monitoring devices market by product Exhibit 07: Global POC blood glucose monitoring devices market by product: Overview Exhibit 08: Technological advancements in global POC blood glucose monitoring devices market Exhibit 09: Global POC blood glucose monitoring devices market by consumables 2016-2021 ($ millions) Exhibit 10: Benefits of instruments Exhibit 11: Global POC blood glucose monitoring devices market by instruments 2016-2021 ($ millions) Exhibit 12: Advantages of different instruments Exhibit 13: Global POC blood glucose monitoring devices market by end-user 2016 (% share) Exhibit 14: Global POC blood glucose monitoring devices market by end-user 2016: Strategic analysis Exhibit 15: Types of reference measurement services available in clinical diagnostic laboratories Exhibit 16: Average cost of blood glucose testing in clinical diagnostic laboratories Exhibit 17: Global POC blood glucose monitoring devices market 2016: Buying criteria analysis Exhibit 18: Life cycle analysis of global POC blood glucose monitoring devices by geographies 2016 Exhibit 19: Global POC blood glucose monitoring devices market by geography 2016 and 2021 ($ millions) Exhibit 20: Market overview of POC blood glucose monitoring devices in Americas Exhibit 21: POC blood glucose monitoring devices market in Americas ($ millions) Exhibit 22: Market overview of POC blood glucose monitoring devices market in EMEA Exhibit 23: POC blood glucose monitoring devices market in EMEA ($ millions) Exhibit 24: Market overview of POC blood glucose monitoring devices market in APAC Exhibit 25: POC blood glucose monitoring devices market in APAC ($ millions) Exhibit 26: Government programs to reduce cost burden for diabetics Exhibit 27: Products recalled by POC blood glucose monitoring device manufacturers Exhibit 28: Competitive structure analysis of global POC blood glucose monitoring devices market 2016 Exhibit 29: Market penetration of vendors in global POC blood glucose monitoring devices market 2016 Exhibit 30: Strategic success factors of companies in global POC blood glucose monitoring devices market 2016 Exhibit 31: Alere: Key highlights Exhibit 32: Alere: Strength assessment Exhibit 33: Alere: Strategy assessment Exhibit 34: Alere: Opportunity assessment Exhibit 35: F. Hoffmann-La Roche: Key highlights Exhibit 36: F. Hoffmann-La Roche: Strength assessment Exhibit 37: F. Hoffmann-La Roche: Strategy assessment Exhibit 38: F. Hoffmann-La Roche: Opportunity assessment Exhibit 39: LifeScan: Key highlights Exhibit 40: LifeScan: Strength assessment Exhibit 41: LifeScan: Strategy assessment Exhibit 42: LifeScan: Opportunity assessment Exhibit 43: Abbott: Company assessment Exhibit 44: Siemens Healthineers: Company assessment

Alere, F. Hoffmann-La Roche, LifeScan, AgaMatrix, A. Menarini Diagnostics, Animas, Ascensia Diabetes Care, Bayer Healthcare, BD, BIOPTIK, DarioHealth, DexCom, EKF Diagnostics, GlySens, HemoCue, Integrity Applications, International Biomedical, Medisana, MediWise, Nemaura, Nipro, Nova Biomedical, Omnis Health, Owen Mumford, Philips Healthcare, Randox Laboratories, Senseonics, and TaiDoc Technology.